0001213900-24-054781.txt : 20240621
0001213900-24-054781.hdr.sgml : 20240621
20240621161523
ACCESSION NUMBER: 0001213900-24-054781
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240621
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gabay Avraham
CENTRAL INDEX KEY: 0001777328
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35813
FILM NUMBER: 241060355
MAIL ADDRESS:
STREET 1: 2/4 HIGH-TECH PARK, P.O. BOX 39098
CITY: JERUSALEM
STATE: L3
ZIP: 91390
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001176309
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980376008
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-844-1164
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Integrated Security Technologies, Inc.
DATE OF NAME CHANGE: 20040614
FORMER COMPANY:
FORMER CONFORMED NAME: IGUANA VENTURES LTD
DATE OF NAME CHANGE: 20020625
4
1
ownership.xml
X0508
4
2024-06-21
0
0001176309
ORAMED PHARMACEUTICALS INC.
ORMP
0001777328
Gabay Avraham
1185 AVENUE OF THE AMERICAS, THIRD FLOOR
NEW YORK
NY
10036
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-06-21
4
A
0
140040
A
0
D
Represents a grant of 140,040 Restricted Stock Units ("RSUs"), of which 93,360 will vest on June 18, 2026 and the remaining 46,680 will vest in four equal quarterly installments of 11,670 starting September 18, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
/s/ Avraham Gabay
2024-06-21